Instituto de Investigación Biomédica de A Coruña (INIBIC)
Research center
Hospital Carlos III
Madrid, EspañaPublications in collaboration with researchers from Hospital Carlos III (79)
2023
-
Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?
ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, Vol. 4, Núm. 2, pp. 138-146
2022
-
Dyslipidemia observatory: Treatment of hypercholesterolemia in Spain, context and levers for improvement in clinical practice
Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 253-260
-
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
BMC Cardiovascular Disorders, Vol. 22, Núm. 1
2020
-
Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on
Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492
2018
-
Adherence to recommendations of the Therapeutic Positioning Report about treatment with oral anticoagulants in elderly patients with atrial fibrillation. The ESPARTA study
Medicina Clinica, Vol. 151, Núm. 1, pp. 8-15
-
Type and doses of oral anticoagulants and adherence to anticoagulant treatment in elderly patients with atrial fibrillation: The ESPARTA study
Journal of Comparative Effectiveness Research, Vol. 7, Núm. 3, pp. 223-232
2017
-
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study
HIV Medicine, Vol. 18, Núm. 7, pp. 482-489
-
Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach
PLoS ONE, Vol. 12, Núm. 9
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
-
MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression
PLoS ONE, Vol. 11, Núm. 5
-
Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment
Archivos de Bronconeumologia, Vol. 52, Núm. 5, pp. 262-268
2015
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
-
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 1, pp. 46-54
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194
-
Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions
PLoS ONE, Vol. 9, Núm. 12
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
-
Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes
International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6
2013
-
Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B
AIDS, Vol. 27, Núm. 14, pp. 2219-2224